Globe Life Inc.
NYSE:GL · New York Stock Exchange
+$2.08 today
Vol 1.64M · Avg 0.53M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:GL · Revenue to Net Income
Key Ratios
Analysis
$6.1B of revenue converted into $1.2B of net income for the selected period. Gross margin is 38.0% and net margin is 19.4%, showing how much revenue survives after costs and taxes. EPS is $14.50, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B +3.8% | $5.8B +6.1% | $5.4B +4.2% | $5.2B +2.1% | $5.1B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $4.0B +2.2% | $3.9B +2.6% | $3.8B +3.3% | $3.7B +7.3% | $3.4B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $2.0B +7.1% | $1.9B +14.0% | $1.6B +6.4% | $1.5B -8.6% | $1.7B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 33.4% +1.0pp | 32.4% +2.3pp | 30.1% +0.6pp | 29.5% -3.5pp | 32.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $197.7M -48.3% | $382.5M +15.3% | $331.9M -0.9% | $335.0M +11.0% | $301.9M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $541.0M -0.5% | $543.6M +21.9% | $446.0M +1.6% | $439.0M +6.5% | $412.4M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $374.2M | $1.2B | $631.8M |
| EBITDA | $1.6B +9.5% | $1.5B +12.1% | $1.3B +8.7% | $1.2B -12.2% | $1.4B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 26.5% +1.4pp | 25.2% +1.4pp | 23.8% +1.0pp | 22.8% -3.7pp | 26.5% | 5.6% | 46.3% | 42.0% |
| Operating Income | $1.5B +10.3% | $1.3B +11.1% | $1.2B +8.4% | $1.1B -13.5% | $1.3B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 24.4% +1.4pp | 23.0% +1.0pp | 21.9% +0.8pp | 21.1% -3.8pp | 24.9% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $141.2M +11.1% | $127.1M +24.2% | $102.3M +13.2% | $90.4M +8.3% | $83.5M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$23.0M | $0 | $0 | $0 | $0 | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.4B +8.5% | $1.3B +11.1% | $1.2B +8.4% | $1.1B -13.5% | $1.3B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 24.0% +1.0pp | 23.0% +1.0pp | 21.9% +0.8pp | 21.1% -3.8pp | 24.9% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $278.6M +8.9% | $255.9M +14.5% | $223.5M +7.6% | $207.7M -14.7% | $243.5M | $1.3B | -$1.6B | $745.2M |
| Net Income | $1.2B +8.4% | $1.1B +10.3% | $970.8M +8.5% | $894.4M -13.3% | $1.0B | $4.9B | $4.8B | $4.7B |
| Net Margin | 19.4% +0.8pp | 18.5% +0.7pp | 17.8% +0.7pp | 17.1% -3.0pp | 20.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $14 +19.3% | $12 +17.4% | $10 +11.8% | $9 +25.1% | $7 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $14 +17.8% | $12 +18.6% | $10 +11.4% | $9 +25.2% | $7 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $80.9M -3.7% | $83.9M -11.7% | $95.1M -2.9% | $97.9M -4.1% | $102.1M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $80.9M -4.6% | $84.7M -12.1% | $96.4M -2.6% | $99.0M -4.1% | $103.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector

MetLife, Inc.
NYSE:MET
$55.24B

Unum Group
NYSE:UNM
$14.64B

Assurant, Inc.
NYSE:AIZ
$12.99B

Aegon Ltd.
NYSE:AEG
$12.89B

American Financial Group, Inc.
NYSE:AFG
$11.08B

Old Republic International Corporation
NYSE:ORI
$9.43B

Grupo Financiero Galicia S.A.
NASDAQ:GGAL
$8.92B

Primerica, Inc.
NYSE:PRI
$8.77B

Lincoln National Corporation
NYSE:LNC
$7.15B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does GL generate?
Globe Life Inc. (GL) reported $6.00B of revenue in fiscal 2025.
Is GL profitable?
Globe Life Inc. (GL) reported $1.16B of net income, with a net margin of 19.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.